L-P Xu

519 citations
14 papers · 400 indexed · h-index 10

Impact in

  • Hematology top 5%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments

Papers in

    • Hematopoietic Stem Cell Transplantation 9
    • Acute Myeloid Leukemia Research 3
    • Chronic Myeloid Leukemia Treatments 2

L-P Xu

14 papers receiving 396 citations

Peers

L-P Xu
Comparison fields: 5 of 33
  • Hematology 354
  • Transplantation 27
  • Immunology 164
  • Genetics 52
  • Oncology 96
Replace Lan‐Ping Xu with:
Lan‐Ping Xu China
S. Vigouroux France
Jane Nunnick United Kingdom
Feng‐Rong Wang China
M-J Zhang United States
D.C. Setubal Brazil
M. G. Kiehl Germany
M. Schaffer Sweden
Brigitte Bär Netherlands
Sally Mokhtari United States
L-P Xu relative to Lan‐Ping Xu China Lan‐Ping Xu's profile →
Citations per field
00.5×1.5×
Lan‐Ping Xu · 1×
Citations per year

Countries citing papers authored by L-P Xu

Since Specialization
Citations

This map shows the geographic impact of L-P Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L-P Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L-P Xu more than expected).

Fields of papers citing papers by L-P Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L-P Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L-P Xu. The network helps show where L-P Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside L-P Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L-P Xu Line = papers co-authored together L-P Xu links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 20205
2 20192
3 201718
4 201614
5 201546
6 201430
7 201421
8 201412
9 201398
10 201184
11 200816
12 200852
13
[Process, mechanism, and research method of fish invasion].
20071
14
[Genetic engineering sugarcane: potential, current status and prospects].
20011

About L-P Xu

L-P Xu is a scholar working on Hematology, Transplantation, Immunology, Genetics and Rheumatology, having authored 14 papers that have together received 400 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (9 papers), Immune Cell Function and Interaction (6 papers), Acute Myeloid Leukemia Research (3 papers), T-cell and B-cell Immunology (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Hematology (354 citations), Transplantation (27 citations), Immunology (164 citations), Genetics (52 citations) and Oncology (96 citations). L-P Xu has collaborated with scholars based in China. Frequent co-authors include Xiao‐Jun Huang, K-Y Liu, D-H Liu, Zhang Xiu, Yu‐Jun Chang, Yen‐Hsu Chen, Haohao Zhu, Ya‐Jen Chang, Song Jin and He Chen. Their work appears in journals such as Bone Marrow Transplantation, British Journal of Cancer, Clinical & Experimental Immunology and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026